Apnimed, Inc.

NASDAQ:APMD

Biotechnology

Healthcare
$17.45 +2.84%

+$0.71 today

Market cap
$726.46M
Beta
0.00

Volume 0.30M

Average 1.15M

Returns on capital

Apnimed, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

No return metrics data available.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Lawrence G. Miller

Founder & Vice Chair of the BoardUSD 805.85K720<0.01%

Dennis Molnar

President & COOUSD 645.8K57——

Kevin Robert Lind

CEO & Director—500<0.01%

Michael Kelly

Chief Financial Officer—51——

Steven W. Spector

Chief Legal Officer & Head of Corporate Affairs—61——

Jennifer Patterson

Senior Vice President of Human Resources————

Leila Sylvain

Senior Manager of Administration————

John W. Cronin

Chief Medical Officer—58——

Luigi Taranto Montemurro

Co-Founder & Chief Scientific Officer—47——

Sean Johnston

Consulting Head of CMC—68——

Compensation is shown in the reported currency; data updated Nov 14, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 3, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

2

$5.20M

Sells

0

$0.00

Net Transaction Value

+$5.20M

Net buying

Most Active

Morningside Venture Investments Ltd

1 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 3, 26

Morningside Venture Investments Ltd

Direct

Buy$5M
Aug 3, 26

SEKHRI PAUL J

Direct

Buy$200K

Summary

Insiders reported 2 buys worth $5.20M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $5.20M. Morningside Venture Investments Ltd was the most active insider with 1 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

No growth data available

Competitors

Who does Apnimed, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about APMD's management, answered from reported figures.

Who manages APMD?

Apnimed, Inc. (APMD) lists 10 active executives. The top listed executive is Kevin Robert Lind, CEO & Director.

Are APMD insiders buying or selling?

Recent insider activity shows net buying of $25.54M.